JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
EV to Sales HistoryNormalizing
Percentile Rank86
3Y CAGR+17.8%
5Y CAGR+8.6%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+17.8%/yr
vs -11.0%/yr prior
5Y CAGR
+8.6%/yr
Recent acceleration
Acceleration
+28.9pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20252.24+27.0%
20241.76+56.1%
20231.13-17.4%
20221.37-53.9%
20212.97+100.8%
20201.48-5.7%
20191.57-28.2%
20182.19-20.3%
20172.74+47.4%
20161.86-